Shandong Boan Biotechnology Co Ltd
HKEX:6955
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shandong Boan Biotechnology Co Ltd
HKEX:6955
|
CN |
|
P
|
Petron Malaysia Refining & Marketing Bhd
KLSE:PETRONM
|
MY |
|
Nokian Tyres plc
OTC:NKRKY
|
FI |
|
Cemedine Co Ltd
TSE:4999
|
JP |
|
Lovesac Co
NASDAQ:LOVE
|
US |
|
N
|
N-Able Inc
NYSE:NABL
|
US |
|
Hotel Holiday Garden
TWSE:2702
|
TW |
Shandong Boan Biotechnology Co Ltd
Shandong Boan Biotechnology Co., Ltd. operates as a biopharmaceutical company that specializes in therapeutic antibody development, manufacturing and commercialization. The company is headquartered in Yantai, Shandong and currently employs 631 full-time employees. The company went IPO on 2022-12-30. The firm is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The firm has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The firm operates mainly in the domestic Chinese market and overseas markets.
Shandong Boan Biotechnology Co., Ltd. operates as a biopharmaceutical company that specializes in therapeutic antibody development, manufacturing and commercialization. The company is headquartered in Yantai, Shandong and currently employs 631 full-time employees. The company went IPO on 2022-12-30. The firm is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The firm has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The firm operates mainly in the domestic Chinese market and overseas markets.